Greater San Diego Biological Solutions
Nonprofit profile at a glance
- EIN
- 884283342
- IRS 990-EZ coverage
- 2022–2025
- Forms available
- Form 990-EZ 2025
- Location
- Encinitas, CA, USA
- Phone
- 7602051104
- Rating
- 92
- Verdict
- STRONG
- Rating confidence
- Moderate
- Sector
- General Science
Reported finances
- Revenue
- $14,884
- Expenses
- $15,254
- Assets
- $2,258
- Liabilities
- $0
Source: IRS Form 990-EZ. Selected filing: tax year 2025. Amounts in USD.
Leadership & pay
5 people listed
Executive titles in this filing
- Jonathan Moore (President CEO Director)
People named in this filing
- Jonathan Moore (President CEO Director)
- Carl Abulencia (Secretary Director)
- Jazell Estadilla Handke (Treasurer CFO Director)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990-EZ. Selected filing: tax year 2025. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
Greater San Diego Biological Solutions is a California nonprofit public benefit research corporation organized for the primary purpose of delivering practical biological solutions to meet critical global health needs.
What it reported doing in 2025
Serving our mission and primary purpose program in FY2025, Greater San Diego Biological Solutions (GSD Bio) moved forward two key collaborations with research teams at the University of Minnesota, one New England Biolabs (a B Corp), and a major San Diego nonprofit immunology research institute. These relationships involved the transfer of GSD Bio-produced materials and knowledge for immunogenicity testing of dengue and Zika virus vaccine prototypes and for a three-year USDA-funded grant for avian influenza vaccine candidate trials in birds. Along with research, GSD Bio further advanced its commoning biology mission by co-producing and implementing an experiential learning module for the California State University San Marcos (CSUSM) Masters in Biotechnology program, directly benefiting 19 graduate students. Additionally, a GSD Bio project program proposal was integrated into a federal Research Experience for Undergraduates (REU) grant renewal, to create access to project-based and purpose-driven biotechnological education for the next generation of scientists.
Operating model
- Revenue model
- Donor-supported. 100% of the money available for current operations came from contributions and gifts.
- Distribution model
- Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.
The verdict
STRONG - A large share of available resources goes toward mission work and the filed numbers largely add up. Program spending has declined or grown slowly and revenue has declined or grown slowly.
Rating breakdown
- Financial Efficiency: 100
- Transparency & Controls: 100
- Sustainability: 37
- Growth: 0
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 100%; rating input score 100
- Program expense ratio: 100%; rating input score 100
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 51st percentile among comparable filings
- Major donor itemization: Yes; rating input score 100
Sustainability
- Operating margin: -2.5%; rating input score 38; 38th percentile among comparable filings
- Total-asset coverage ratio: 0.15; rating input score 15; 15th percentile among comparable filings
- Liabilities to assets ratio: 0; rating input score 66; 66th percentile among comparable filings
- Officer compensation ratio: 0%; rating input score 56; 56th percentile among comparable filings
Growth
- Program expense growth: -15.6% per year; rating input score 0; 22nd percentile among comparable filings
- Revenue growth: -27% per year; rating input score 0; 12th percentile among comparable filings
- Asset growth: -82.5% per year; rating input score 0; 2nd percentile among comparable filings
Details
- Where the money goes: 100% of revenue deployed · 100% of spending went to programs
- Governance: Filed governance answers
- Accomplishments: 1 filed program accomplishment · $15K in reported program spending
- Leadership: top reported pay $0 · 5 people listed
- Consistency: 9 of 9 current checks pass
- Schedules: 3 filed schedules
- Filing history: 4 filing years from 2022 to 2025
- Contacts: How to reach this organization
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Growth: Program expense growth scored 0/100.
- High — Growth: Revenue growth scored 0/100.
- Moderate — Sustainability: Operating margin scored 38/100.
- High — Sustainability: Total-asset coverage ratio scored 15/100.
- High — Growth: Asset growth scored 0/100.
- Review — Sustainability: Officer compensation ratio scored 56/100.